Mark Sullivan, MD, PhD

Personal Statement

My clinical service and research focuses on the interaction of mental and physical illness, especially in patients with chronic pain or heart disease. Much of my research in the past decade has focused on the risks of treating chronic pain with opioids. I have developed educational programs and outcome tracking tools to assist with opioid treatment of chronic pain. I am interested in expanding the role for the patient in the care of chronic illness and am completing a book on this topic.​

Education

Vanderbilt Univ. Sch. of Medicine Medical education, 1984
Univ. of Missouri Columbia Internship, Family Medicine
UW - Dept. of Psychiatry & Behavioral Sciences Residency, Psychiatry

Department Affiliations

Teaching Philosophy

​I like to have trainees manage patients under my supervision. Trainees need real responsibility to learn and develop management skills.
In didactic sessions, I strive for interaction between myself and trainees. I generally teach in a seminar format centered around case presentations. I expect all trainees to contribute to the discussion and the learning of others.

Recent Publications

When Physical and Social Pain Coexist: Insights Into Opioid Therapy.
(2021 Jan-Feb)
Ann Fam Med 19(1): 79-82
Sullivan MD, Ballantyne JC

Is obesity associated with odds of prescription opioid use independent of depression?
(2021 Jan)
Pain 162(1): 319
Scherrer JF, Sullivan MD

Green synthesis as a simple and rapid route to protein modified magnetic nanoparticles for use in the development of a fluorometric molecularly imprinted polymer-based assay for detection of myoglobin.
(2021 Feb 26)
Nanotechnology 32(9): 095502
Sullivan MV, Stockburn WJ, Hawes PC, Mercer T, Reddy SM

The association of opioid use duration and new depression episode among patients with and without insomnia.
(2020 Sep/Oct 2020)
J Opioid Manag 16(5): 317-328
Salas J, Miller MB, Scherrer JF, Moore R, McCrae CS, Sullivan MD, Bucholz KK, Copeland LA, Ahmedani BK, Schneider FD, Lustman PJ

A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and Evaluation.
(2020)
Perm J 24():
Kuntz JL, Schneider JL, Firemark AJ, Dickerson JF, Papajorgji-Taylor D, Reese KR, Hamer TA, Marsh D, Thorsness LA, Sullivan MD, Debar LL, Smith DH

Show complete publication list »
Edit Profile